Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-29 Sale | 2024-07-29 5:24 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,251 | $5.9203 | $13,327 | 229,398 (Indirect Direct) | View |
| 2024-03-04 Sale | 2024-03-06 4:46 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 14,700 | $4.3124 | $63,393 | 231,649 (Indirect Direct) | View |
| 2023-07-28 Sale | 2023-08-01 4:30 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,212 | $6.3041 | $13,945 | 121,349 (Indirect Direct) | View |
| 2023-06-15 Sale | 2023-06-20 4:34 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 16,000 | $6.2944 | $100,710 | 123,561 (Indirect Direct) | View |
| 2023-03-02 Sale | 2023-03-06 6:25 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 13,934 | $6.2684 | $87,344 | 139,561 (Indirect Direct) | View |
| 2022-12-06 Sale | 2022-12-07 5:56 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 4,792 | $10.61 | $50,827 | 120,795 (Indirect Direct) | View |
| 2022-07-28 Sale | 2022-08-01 4:45 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,239 | $10.97 | $24,562 | 118,087 (Indirect Direct) | View |
| 2022-03-01 Sale | 2022-03-02 9:27 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 12,305 | $11.26 | $138,513 | 197,826 (Indirect Direct) | View |
| 2021-07-28 Sale | 2021-07-30 09:15 am | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 2,130 | $19.24 | $40,973 | 99,931 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:40 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 9,371 | $18.35 | $171,971 | 102,061 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-16 Option Award | 2024-02-21 4:52 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 125,000 | $0 | 246,349 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:09 pm | N/A 2033-02-15 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 110,200 | $0 | 230,995 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-07 5:56 pm | N/A 2022-12-06 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 7,500 | $0 | 120,795 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-07 5:56 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 7,500 | $3.12 | 120,795 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:27 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 110,200 | $0 | 197,826 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:17 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 110,200 | $0 | 188,932 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-29 8:19 pm | N/A 2030-07-26 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer | 107,344 | $0 | 168,732 (Direct) | View |
Ownership | 2020-03-24 4:10 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick VP, Acting CFO & Treasurer | 0 | $0 | 105,638 (Direct) | View |